FDA Staff Weighs In on Potential First mRNA Flu Shot
Ahead of an advisory committee meeting this week, FDA reviewers raised no serious efficacy or safety concerns about Moderna’s mRNA flu vaccine candidate for adults 50 and older, which has…
In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
James Mu had braced for the call that came in late January. A patient from his rural Northern California county had measles, a disease so rare there that many physicians…
